Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Low Vision: full-pipeline trial registry

4 of 9 indexed Low Vision trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Low Vision: 9 US clinical trials tracked, 4 recruiting.

Low Vision is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Los Angeles, running 2 of these trials.

Enrollment posture brief

Registry condition low-vision

OPEN 4 | RECR 44% | LATE 1 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Low Vision (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Low Vision

Low Vision lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Low Vision on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Low Vision is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Low Vision research.

    University of California, Los Angeles accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Low Vision enrolment sits around 50 participants.

    Median target enrolment is 50 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Low Vision research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Named interventions

Most-linked intervention names on Low Vision records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Low Vision Rehabilitation Behavioral
2 trials
Iopcl AMD MAG Device
1 trials
Visual impairment intervention program Procedure
1 trials
SmartHMD version 4 Device
1 trials
SmartHMD version 3 Device
1 trials
SmartHMD version 2 Device
1 trials
SmartHMD version 1 Device
1 trials
Obstacle characteristics Other
1 trials

US sites by state

Facility locations filed on Low Vision trials. A trial with sites in several states counts in each.

California 4 trials
Michigan 2 trials
Massachusetts 2 trials
Texas 1 trials
Nebraska 1 trials
Maryland 1 trials
Indiana 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Low Vision page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Low Vision condition card totals 9 registered trials; most-linked intervention Low Vision Rehabilitation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.